April 21, 2025 8:55 PM

Latest:

US Agrees To Link Ukraine Minerals Deal To Budapest Memorandum … As White House Appears To Remove Document
Miami Housing Market Shows Dramatic Cooling as Florida Boom Fades
Can Alberta Succeed Where Decades of Canadian High-Speed Rail Plans Have Failed?
This Potash Project Is Critical for Global Food Security | Mayo Schmidt – Brazil Potash
Russia’s Hollow Easter Ceasefire Exposed by Immediate Assaults on Ukraine

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Cannabis
- Commentary
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Resources
- Technology
Resources
Energy
Technology
Coverage Companies
Verses AI
About
Contact Us

Carney, Not Poilievre, Getting Credit for Axing the Carbon Tax

Latest

US Agrees To Link Ukraine Minerals Deal To Budapest Memorandum … As White House Appears To Remove Document
Miami Housing Market Shows Dramatic Cooling as Florida Boom Fades
Can Alberta Succeed Where Decades of Canadian High-Speed Rail Plans Have Failed?
This Potash Project Is Critical for Global Food Security | Mayo Schmidt – Brazil Potash
Russia’s Hollow Easter Ceasefire Exposed by Immediate Assaults on Ukraine
Musk Prepares Exit, Can’t Handle the Heat of His Own Accountability Furnace
Are Colleges Cashing In Endowments As Political Pressure Mounts?
China Warns of Retaliation for Countries Backing US Trade Tactics

Video

This Potash Project Is Critical for Global Food Security | Mayo Schmidt – Brazil Potash

April 21, 2025 1:41 PM JP Alegre 0

In this exclusive interview, Mayo Schmidt, former CEO of Nutrien and Executive Chairman of Brazil Potash (NYSE: GRO), provides a compelling analysis of the company’s potential in the potash market. Schmidt reveals how Brazil’s 98% reliance on imported potash creates a unique investment opportunity, with the company projecting $1B in annual EBITDA by 2029.

Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
'Do You Believe the Polls?' Campaign Fuels Ford-Poilievre Feud
Tariffied! Cleveland-Cliffs Not Immune To Market Meltdown
Kinross Gold: Fire Shuts Down Their Largest Operation
China Boosts Canadian Oil Imports as Trade War With US Intensifies

News

Biotech Latest News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Stocktwits Partners with Beehiiv to Launch Newsletter Platform for Finance Writers

April 16, 2025 2:54 PM JP Alegre 0

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Leave a ReplyCancel reply